Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046337310> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2046337310 endingPage "424s" @default.
- W2046337310 startingPage "424s" @default.
- W2046337310 abstract "Atovaquone and proguanil hydrochloride are blood schizonticides that demonstrate in vitro synergy against drug-resistant strains of Plasmodium falciparum. When coadministered, they may therefore be effective for the treatment of malaria in regions where there is known or suspected drug resistance. In an open-label, randomized, parallelgroup, clinical trial conducted in Zambia, 163 patients (age range, 14 to 54 years) with acute P falciparum malaria were randomly assigned to receive treatment with atovaquone and proguanil hydrochloride (1000 and 400 mg, respectively, administered orally at 24-hour intervals for 3 doses; n = 82) or pyrimethamine/sulfadoxine (75/1500 mg administered orally as a single dose; n = 81). Efficacy was assessed by cure rate (the percentage of patients in whom parasitemia was eliminated and did not recur during 28 days of follow-up), parasite clearance time (PCT), and fever clearance time (FCT). Safety was determined by sequential clinical and laboratory assess ments over 28 days. Cure rates did not differ significantly between patients treated with atovaquone and proguanil (100%) and those treated with pyrimethamine/ sulfadoxine (98.8%). Patients in the atovaquone and proguanil group had a significantly shorter FCT than patients in the pyrimethamine/sulfadoxine group (mean, 30.4 vs 44.9 hours; P < 0.05) but a longer PCT (mean, 64.0 vs 51.4 hours; P < 0.05). Both treatments were well tolerated; adverse events and laboratory abnormalities were typical of those normally observed in patients with malaria. In this study, the combination of atovaquone and proguanil was equally effective and as well tolerated as pyrimethamine/sulfadoxine for the treatment of acute, uncomplicated, drugresistant falciparum malaria in Zambia." @default.
- W2046337310 created "2016-06-24" @default.
- W2046337310 creator A5019495658 @default.
- W2046337310 creator A5020252681 @default.
- W2046337310 creator A5021139470 @default.
- W2046337310 creator A5052332524 @default.
- W2046337310 creator A5061821450 @default.
- W2046337310 date "2003-12-01" @default.
- W2046337310 modified "2023-10-14" @default.
- W2046337310 title "Prise en charge du paludisme d'importation en France (2001–2002). Évaluation de l'association atovaquone-proguanil dans le traitement de l'accès non compliqué à Plasmodium falciparum" @default.
- W2046337310 doi "https://doi.org/10.1016/s0248-8663(03)80429-0" @default.
- W2046337310 hasPublicationYear "2003" @default.
- W2046337310 type Work @default.
- W2046337310 sameAs 2046337310 @default.
- W2046337310 citedByCount "0" @default.
- W2046337310 crossrefType "journal-article" @default.
- W2046337310 hasAuthorship W2046337310A5019495658 @default.
- W2046337310 hasAuthorship W2046337310A5020252681 @default.
- W2046337310 hasAuthorship W2046337310A5021139470 @default.
- W2046337310 hasAuthorship W2046337310A5052332524 @default.
- W2046337310 hasAuthorship W2046337310A5061821450 @default.
- W2046337310 hasConcept C126322002 @default.
- W2046337310 hasConcept C203014093 @default.
- W2046337310 hasConcept C2775867548 @default.
- W2046337310 hasConcept C2777035104 @default.
- W2046337310 hasConcept C2778048844 @default.
- W2046337310 hasConcept C2778301690 @default.
- W2046337310 hasConcept C2778371730 @default.
- W2046337310 hasConcept C2779124865 @default.
- W2046337310 hasConcept C2779636613 @default.
- W2046337310 hasConcept C2780441369 @default.
- W2046337310 hasConcept C71924100 @default.
- W2046337310 hasConcept C98274493 @default.
- W2046337310 hasConceptScore W2046337310C126322002 @default.
- W2046337310 hasConceptScore W2046337310C203014093 @default.
- W2046337310 hasConceptScore W2046337310C2775867548 @default.
- W2046337310 hasConceptScore W2046337310C2777035104 @default.
- W2046337310 hasConceptScore W2046337310C2778048844 @default.
- W2046337310 hasConceptScore W2046337310C2778301690 @default.
- W2046337310 hasConceptScore W2046337310C2778371730 @default.
- W2046337310 hasConceptScore W2046337310C2779124865 @default.
- W2046337310 hasConceptScore W2046337310C2779636613 @default.
- W2046337310 hasConceptScore W2046337310C2780441369 @default.
- W2046337310 hasConceptScore W2046337310C71924100 @default.
- W2046337310 hasConceptScore W2046337310C98274493 @default.
- W2046337310 hasLocation W20463373101 @default.
- W2046337310 hasOpenAccess W2046337310 @default.
- W2046337310 hasPrimaryLocation W20463373101 @default.
- W2046337310 hasRelatedWork W1746729210 @default.
- W2046337310 hasRelatedWork W1969218147 @default.
- W2046337310 hasRelatedWork W2065689323 @default.
- W2046337310 hasRelatedWork W2089939861 @default.
- W2046337310 hasRelatedWork W2106552226 @default.
- W2046337310 hasRelatedWork W2147010472 @default.
- W2046337310 hasRelatedWork W2437441723 @default.
- W2046337310 hasRelatedWork W4254685074 @default.
- W2046337310 hasRelatedWork W2069315752 @default.
- W2046337310 hasRelatedWork W2182024691 @default.
- W2046337310 hasVolume "24" @default.
- W2046337310 isParatext "false" @default.
- W2046337310 isRetracted "false" @default.
- W2046337310 magId "2046337310" @default.
- W2046337310 workType "article" @default.